AbSci Named Washington 100 Best Companies to Work For
We’re excited to announce that AbSci made Seattle Business Magazine’s list of Washington’s 100 Best Companies to Work For! This year marks the 29th annual release of the Seattle Business Magazine’s 100 Best Companies to Work For list, as they look for the top...
AbSci Raises Oversubscribed $12M Series C to Fuel Commercialization of Its Groundbreaking Protein Expression Platform
The Series C Round led by Asahi Glass Co., Ltd. “AGC” includes participation from all prior investors (Phoenix Venture Partners, Oregon Venture Fund, WRF Capital, and Souther Co.) and new investors Columbia Ventures Corporation and GreenBridge.
Sean McClain of AbSci Entrepreneur Of The Year® 2018 Award Finalist in the Pacific Northwest
EY Announces Sean McClain of AbSci Entrepreneur Of The Year® 2018 Award Finalist in the Pacific Northwest region Vancouver, Washington May 7th, 2018 – EY announced that Founder and CEO Sean McClain of AbSci is a finalist for the Entrepreneur Of The Year® 2018 Award in...
AbSci hopes to make E. Coli great again through engineered expression system
AbSci says its genetically engineered E. coli expression platform has produced yields exceeding 20 g/L for difficult to express products and threatens the dominance of mammalian systems …
AbSci Adds Protein Characterization Expert, Alan Herman, PhD to Scientific Advisory Board
“There’s an electricity of discovery here like Genentech and Amgen,” said Dr. Herman. “AbSci’s ability to fold proteins is an innovative art form. This technology enables more efficient manufacturing, which will bring down the price of drugs.”
AbSci Appoints William F. Bennett, PhD to Scientific Advisory Board
“The culture here reminds me of Genentech in the early days. It’s an honor to join the team as a Scientific Advisor,” said Dr. Bennett. “AbSci’s technology is a quantum improvement in bacterial expression systems.”
AbSci at 36th JP Morgan Conference January 8th – 11th.
AbSci Appoints Fred Larimore, PhD to Scientific Advisory Board
AbSci announced today the appointment of Fred Larimore, PhD to AbSci’s Scientific Advisory Board. Dr. Larimore brings over 30 years of experience in biopharmaceutical manufacturing and process development at leading pharmaceutical companies …
2017: A Big Year for AbSci – Growth and Continued Expansion
AbSci, a global leader in breakthrough biomanufacturing technologies, today announced that it is further expanding its offices and laboratory facilities. “We’ve seen a significant increase in partnership deal flow, which is a testament to the innovation and quality of work performed by our scientists,” said CEO and Founder, Sean McClain …
AbSci named PBJ’s Small Business Innovation Award Winner for 2017
AbSci to be named one of Portland's most innovative companies of the year. The awards ceremony will take place at Portland's Hilton Hotel Wednesday, November 1st. You can read more about the event here.